RTW Investments, LP 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 10:22 am Sale | 2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | RTW Investments, LP | 0 0.000% | -6,029,700 (Position Closed) | Filing |
| 2022-02-14 08:58 am Purchase | 2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | RTW Investments, LP | 6,029,700 9.200% | 161,374 (+2.75%) | Filing |
| 2021-12-08 2:06 pm Purchase | 2021-11-29 | 13G | CytomX Therapeutics, Inc. CTMX | RTW Investments, LP | 5,868,326 8.990% | 5,868,326 (New Position) | Filing |